Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm.
Philippe L, Ceroi A, Bôle-Richard E, Jenvrin A, Biichle S, Perrin S, Limat S, Bonnefoy F, Deconinck E, Saas P, Garnache-Ottou F, Angelot-Delettre F. Philippe L, et al. Among authors: deconinck e. Haematologica. 2017 Nov;102(11):1861-1868. doi: 10.3324/haematol.2017.169326. Epub 2017 Aug 10. Haematologica. 2017. PMID: 28798071 Free PMC article.
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.
Garnache-Ottou F, Chaperot L, Biichle S, Ferrand C, Remy-Martin JP, Deconinck E, de Tailly PD, Bulabois B, Poulet J, Kuhlein E, Jacob MC, Salaun V, Arock M, Drenou B, Schillinger F, Seilles E, Tiberghien P, Bensa JC, Plumas J, Saas P. Garnache-Ottou F, et al. Among authors: deconinck e. Blood. 2005 Feb 1;105(3):1256-64. doi: 10.1182/blood-2004-06-2416. Epub 2004 Sep 23. Blood. 2005. PMID: 15388576 Free article.
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Ducastelle S, Adès L, Gardin C, Dombret H, Prébet T, Deconinck E, Rio B, Thomas X, Debotton S, Guerci A, Gratecos N, Stamatoullas A, Fegueux N, Dreyfus F, Fenaux P, Wattel E. Ducastelle S, et al. Among authors: deconinck e. Haematologica. 2006 Mar;91(3):373-6. Haematologica. 2006. PMID: 16531261
Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphoma.
Fagnoni P, Milpied N, Limat S, Deconinck E, Nerich V, Foussard C, Colombat P, Harousseau JL, Woronoff-Lemsi MC; Groupe Ouest-Est des Leucémies et des Autres Maladies du Sang. Fagnoni P, et al. Among authors: deconinck e. Pharmacoeconomics. 2009;27(1):55-68. doi: 10.2165/00019053-200927010-00006. Pharmacoeconomics. 2009. PMID: 19178124
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadié M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, Foisseaud V, Macintyre E, Bene MC, Saas P, Jacob MC; GOELAMS and GEIL study. Garnache-Ottou F, et al. Among authors: deconinck e. Br J Haematol. 2009 Jun;145(5):624-36. doi: 10.1111/j.1365-2141.2009.07679.x. Epub 2009 Apr 8. Br J Haematol. 2009. PMID: 19388928 Free article.
Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance.
Henry C, Deschamps M, Rohrlich PS, Pallandre JR, Rémy-Martin JP, Callanan M, Traverse-Glehen A, GrandClément C, Garnache-Ottou F, Gressin R, Deconinck E, Salles G, Robinet E, Tiberghien P, Borg C, Ferrand C. Henry C, et al. Among authors: deconinck e. Blood. 2010 Mar 25;115(12):2420-9. doi: 10.1182/blood-2009-06-229112. Epub 2010 Jan 20. Blood. 2010. PMID: 20089966 Free article.
363 results